Table 2. Baseline and endpoint scores of clinical variables.
| Baseline (n=69) | Follow-up (n=55) | p-value | Cohen’s d | |
|---|---|---|---|---|
| MMSE | 21.4±3.5 | 19.4±4.6 | 0.001* | 0.41 |
| CSDD | 6.4±5.7 | 7.2±4.5 | 0.264 | -0.12 |
| PFAQ | 12.2±8.2 | 16.0±9.2 | 0.001* | -0.36 |
| NPI | 10.8±10.9 | 14.2±10.9 | 0.020† | -0.25 |
| ZBI | 30.2±16.1 | 30.4±18.6 | 0.083 | -0.00 |
| QoL-AD PwD | 32.4±3.6 | 31.9±5.5 | 0.894 | 0.09 |
| QoL-AD caregivers | 29.8±6.1 | 31.8±5.6 | 0.049† | -0.27 |
| ASPIDD | 5.0±4.0 | 6.6±4.2 | 0.001* | -0.32 |
Data presented as mean ± standard deviation unless otherwise specified.
ASPIDD = Assessment Scale of Psychosocial Impact of the Diagnosis of Dementia; CSDD = Cornell Scale for Depression in Dementia; MMSE = Mini-Mental State Examination; NPI = Neuropsychiatric Inventory; PFAQ = Pfeffer Functional Activities Questionnaire; PwD = people with dementia; QoL-AD = Quality of Life in Alzheimer’s Disease; ZBI = Zarit Burden Interview.
*
p ≤ 0.001, †p ≤ 0.05.